Arbutus Biopharma Corp reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Warminster, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Arbutus Biopharma Corp has filed 1,046 SEC EDGAR filings since 30 Sep 2008

SEC filing history

Showing 26-40 of 40 matching filings.

Per page
25
Current page
2
10-Q File 001-34949

10-Q ARBUTUS Q1 2018 10-Q

Filing date
04 May 2018
Reporting date
31 Mar 2018
Next action
Verify source filing
10-Q File 001-34949

10-Q Q3 2017 ARBUTUS BIOPHARMA

Filing date
02 Nov 2017
Reporting date
30 Sep 2017
Next action
Verify source filing
10-Q File 001-34949

10-Q Q2 2017 ARBUTUS BIOPHARMA

Filing date
03 Aug 2017
Reporting date
30 Jun 2017
Next action
Verify source filing
10-Q File 001-34949

10-Q Q1 2017 ARBUTUS BIOPHARMA CORP

Filing date
04 May 2017
Reporting date
31 Mar 2017
Next action
Verify source filing
10-Q/A File 001-34949

10-Q/A filing

Filing date
22 Dec 2016
Reporting date
30 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34949

10-Q Q3 2016 ARBUTUS

Filing date
03 Nov 2016
Reporting date
30 Sep 2016
Next action
Verify source filing
10-Q File 001-34949

ARBUTUS Q2 2016 10-Q

Filing date
04 Aug 2016
Reporting date
30 Jun 2016
Next action
Verify source filing
10-Q File 001-34949

10-Q Q1 2016 ARBUTUS BIOPHARMA CORP

Filing date
04 May 2016
Reporting date
31 Mar 2016
Next action
Verify source filing
10-Q/A File 001-34949

FORM 10-Q/A

Filing date
15 Jul 2015
Reporting date
31 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .